跳至主要内容
临床试验/JPRN-UMIN000014195
JPRN-UMIN000014195已完成未知

Study on the utility, and palatability of meal in novel SGLT-2 inhibitor ipragliflozin - Study on the utility, and palatability of meal in novel SGLT-2 inhibitor ipragliflozin

Association of medical corporation Ouitsu-kai, Kanno-naika0 个研究点目标入组 50 人开始时间: 2014年6月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) With severe ketosis, history of diabetic or precoma, severe infection, pre or post surgery, and severe trauma, hypersensitivity to ipragliflozin or any other excipient of ipragriflozin 2) With hypophyseal dysfunction or adrenal insufficiency who have high possibility of induces hypoglycemia 3) With urinary tract or genital infection 4) With severe hepatic dysfunction 5) Is receiving SGLT-2 inhibitors at initiation of this study 6) Is nursing or pregnant or planned to become pregnant 7) Considered as inadequate by the investigator

研究者

发起方
Association of medical corporation Ouitsu-kai, Kanno-naika

相似试验